Newsletter/Booklets 7th Jul 2023

Market Access Barriers in The Pharmaceutical Sector in India’s Key Export Destinations

Authors

Sanjay Notani Partner | Mumbai
Parthsarathi Jha Partner | New Delhi | Noida
Naghm Ghei Principal Associate | Delhi NCR
Harika Bakaraju Principal Associate | Mumbai
Divyashree Suri Senior Associate | Delhi NCR
Mitul Kaushal Consultant | Delhi NCR

Latest Thought Leadership

Articles 26th Jul 2024

GST Amnesty Scheme: A Positive Step Towards Reducing Litigation before the upcoming GST Tribunal

Read More
Alerts & Updates 26th Jul 2024

Guarantor Liability under IBC and Contract Act – Critical Gaps in the application of Principle of Subrogation

Read More
News & Media 26th Jul 2024

Judgement that will alter both federal and mineral tax landscape

Read More
News & Media 26th Jul 2024

Mineral merry for states: Centre does not have sole claim on royalties, says Supreme Court

Read More

This report examines the regulatory environment of some of India’s key trading partners, with a view to identify existing and potential trade barriers in exporting pharmaceuticals in these markets.  This serves as a ready reckoner and comprehensive guide for the pharmaceutical industry.

Click here